MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 355 filers reported holding MEDIVATION INC in Q3 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $295,000 | -83.1% | 6,950 | -54.6% | 0.10% | -82.4% |
| Q2 2015 | $1,748,000 | -2.5% | 15,310 | +10.3% | 0.56% | +4.3% |
| Q1 2015 | $1,792,000 | +75.3% | 13,885 | +35.3% | 0.54% | +78.7% |
| Q4 2014 | $1,022,000 | -13.2% | 10,260 | -13.8% | 0.30% | -13.5% |
| Q3 2014 | $1,177,000 | +18.2% | 11,900 | -7.9% | 0.35% | +5.8% |
| Q2 2014 | $996,000 | +0.3% | 12,925 | -16.2% | 0.33% | -6.0% |
| Q1 2014 | $993,000 | – | 15,430 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |